Company WuXi Biologics (Cayman) Inc. Hong Kong S.E.
Equities
2269
KYG970081090
Biotechnology & Medical Research
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics
88.8
%
| 2,582 | 14.5 % | 16,717 | 88.8 % | +547.32% |
XDC
11.2
%
| - | - | 2,106 | 11.2 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
47.4
%
| 9,880 | 55.6 % | 8,921 | 47.4 % | -9.71% |
Europe
30.2
%
| 2,961 | 16.7 % | 5,681 | 30.2 % | +91.85% |
China
18.3
%
| 4,325 | 24.4 % | 3,449 | 18.3 % | -20.24% |
Rest of the World
4.1
%
| 590 | 3.3 % | 772 | 4.1 % | +30.89% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 31/05/11 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 22/08/21 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Weichang Zhou
BRD | Director/Board Member | 59 | 30/11/12 |
Yue Huang
SEC | Corporate Secretary | - | 19/11/18 |
Ying Man Sham
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 05/05/23 |
William Keller
BRD | Director/Board Member | 75 | 16/05/17 |
Ge Li
CHM | Chairman | 56 | 30/04/10 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 30/04/16 |
Yi Bing Wu
BRD | Director/Board Member | 55 | 30/04/16 |
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 31/05/11 |
Weichang Zhou
BRD | Director/Board Member | 59 | 30/11/12 |
Kenneth Hitchner
BRD | Director/Board Member | 63 | 08/06/20 |
Jue Chen
BRD | Director/Board Member | 54 | 15/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,280,124,252 | 3,658,512,235 ( 85.48 %) | 17,642,323 ( 0.4122 %) | 85.48 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
WuXi Biologics (Hong Kong) Ltd.
|
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |